Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 696
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2013  |  Volume : 61  |  Issue : 4  |  Page : 172-175

Assessment of metamorphopsia in patients with central serous chorioretinopathy


Department of Ophthalmology, School of Medicine, Chungbuk National University, Chungbuk, Cheongju, Korea

Correspondence Address:
Ju Byung Chae
Department of Ophthalmology, School of Medicine, Chungbuk National University, Chungbuk, Cheongju
Korea
Login to access the Email id

Source of Support: This work was supported by the research grant of the Chungbuk National University in 2011, Conflict of Interest: None


DOI: 10.4103/0301-4738.112162

Rights and Permissions

Background: To evaluate the presence and extent of metamorphopsia using M-CHARTS TM (Inami Co., Tokyo, Japan) in patients with central serous chorioretinopathy (CSC). Design: Retrospective consecutive medical record review in a university hospital. Materials and Methods: We examined 33 eyes of 33 consecutive CSC patients using M-CHARTS, which yields scores reflecting the severity of metamorphopsia. The condition was considered present when an M-CHARTS score was 0.3 or over. In all patients, optical coherence tomography (OCT) was performed, best-corrected visual acuity (BCVA) was assessed, and M-CHARTS scores were calculated at the first and the 1- and 3-month follow-up visits. The correlation between M-CHARTS scores and BCVA values was determined. We also sought to define relationships between the level of metamorphopsia and specific OCT findings. Results: Of 33 CSC patients, 15 showed symptoms of metamorphopsia, and all 15 had M-CHARTS scores of over 0.3. However, no correlation was evident between BCVA values and the extent of metamorphopsia as determined using M-CHARTS. In metamorphopsia patients, the incidence of focal retinal pigment epithelial detachment was notably greater than in the non-metamorphopsia group (P = 0.03). Conclusion: M-CHARTS is valuable for monitoring subjective symptom improvement during the clinical course of CSC. M-CHARTS serves as a useful adjunct to OCT.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3633    
    Printed27    
    Emailed2    
    PDF Downloaded243    
    Comments [Add]    
    Cited by others 1    

Recommend this journal